Company profile
Adia Nutrition, Inc.
OTC: ADIA · Healthcare · Medical - Pharmaceuticals
#910 of 1,422 Healthcare companies by revenuetop-decile growth
EA Score
29DFH 43DQ 4GM —SS 40
v0.1 · 55/100 weight · provisional
↑ revenue growth (YoY), listing tenure · ↓ disclosure history, filing timeliness
Methodology →Revenue TTM
$700.5k
Rev growth YoY (TTM)
needs 8 qtrs
Net income (FY)
-$395.5k
Employees
3
as of 2026-08-02
Market cap
$14.1M
as of 2026-08-02
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$700.5k$700.5k2025
Net income-$395.5k-$395.5k2025
Operating income-$366.5k-$366.5k2025
Total assets$594.8k$594.8k2025
Liabilities$852.5k$852.5k2025
Equity-$257.7k-$257.7k2025
Revenue by segment
Filed disclosures · FY2025
By product
Biologics99%
Services1%
By geography
Not disclosed.
The read
What is Adia Nutrition, Inc.’s revenue?
Adia Nutrition, Inc. booked $700.5k in FY2025 revenue, growing 10880% year over year — faster than 99% of Healthcare companies we track, at a -56.5% net margin.
Peers · Healthcare
Applied Biosciences Corp.——Lexaria Bioscience Corp.44DHarvard Apparatus Regenerative Technology Inc.41DUnicycive Therapeutics, Inc.32DSETO Holdings, Inc.54DLexeo Therapeutics, Inc. Common Stock37DKey facts
CEOLarry Powalisz
SectorHealthcare
IndustryMedical - Pharmaceuticals
HeadquartersKurtistown, HI
ExchangeOTC: ADIA
Employees3
IPO date2012-04-11
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.